[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diabetes Devices and Drugs Market - Global Outlook and Forecast 2021-2027

April 2021 | 105 pages | ID: DE9578EDC9DCEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Diabetes Devices and Drugs in Global, including the following market information:

Global Diabetes Devices and Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Diabetes Devices and Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Devices and Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Devices and Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Diabetes Devices and Drugs Market Segment Percentages, By Type, 2020 (%)
  • Diabetes Devices
  • Diabetes Drugs
China Diabetes Devices and Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Diabetes Devices and Drugs Market Segment Percentages, By Application, 2020 (%)
  • Diagnostic/Clinics
  • ICUs
  • Home Healthcare
Global Diabetes Devices and Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Diabetes Devices and Drugs Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Diabetes Devices and Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Diabetes Devices and Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Medtronic
  • BD
  • Johnson & Johnson
  • Abbott Laboratories
  • Novo Nordisk
  • Bristol-Myers Squibb
  • DexCom
  • Companion Medical
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Novartis
  • Roche
  • Sanofi
  • MSD
  • Astrazeneca
  • Takeda
  • North China Pharmaceutical Group Corporation
  • Huadong Medicine
  • Dongbao Pharmaceutical
  • Hisun Pharmacy
  • KELUN
  • Ginwa
  • Tianan Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetes Devices and Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetes Devices and Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETES DEVICES AND DRUGS OVERALL MARKET SIZE

2.1 Global Diabetes Devices and Drugs Market Size: 2021 VS 2027
2.2 Global Diabetes Devices and Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetes Devices and Drugs Players in Global Market
3.2 Top Global Diabetes Devices and Drugs Companies Ranked by Revenue
3.3 Global Diabetes Devices and Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Devices and Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Diabetes Devices and Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Devices and Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Diabetes Devices and Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetes Devices and Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Diabetes Devices and Drugs Market Size Markets, 2021 & 2027
  4.1.2 Diabetes Devices
  4.1.3 Diabetes Drugs
4.2 By Type - Global Diabetes Devices and Drugs Revenue & Forecasts
  4.2.1 By Type - Global Diabetes Devices and Drugs Revenue, 2016-2021
  4.2.2 By Type - Global Diabetes Devices and Drugs Revenue, 2022-2027
  4.2.3 By Type - Global Diabetes Devices and Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetes Devices and Drugs Market Size, 2021 & 2027
  5.1.2 Diagnostic/Clinics
  5.1.3 ICUs
  5.1.4 Home Healthcare
5.2 By Application - Global Diabetes Devices and Drugs Revenue & Forecasts
  5.2.1 By Application - Global Diabetes Devices and Drugs Revenue, 2016-2021
  5.2.2 By Application - Global Diabetes Devices and Drugs Revenue, 2022-2027
  5.2.3 By Application - Global Diabetes Devices and Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Diabetes Devices and Drugs Market Size, 2021 & 2027
6.2 By Region - Global Diabetes Devices and Drugs Revenue & Forecasts
  6.2.1 By Region - Global Diabetes Devices and Drugs Revenue, 2016-2021
  6.2.2 By Region - Global Diabetes Devices and Drugs Revenue, 2022-2027
  6.2.3 By Region - Global Diabetes Devices and Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Diabetes Devices and Drugs Revenue, 2016-2027
  6.3.2 US Diabetes Devices and Drugs Market Size, 2016-2027
  6.3.3 Canada Diabetes Devices and Drugs Market Size, 2016-2027
  6.3.4 Mexico Diabetes Devices and Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Diabetes Devices and Drugs Revenue, 2016-2027
  6.4.2 Germany Diabetes Devices and Drugs Market Size, 2016-2027
  6.4.3 France Diabetes Devices and Drugs Market Size, 2016-2027
  6.4.4 U.K. Diabetes Devices and Drugs Market Size, 2016-2027
  6.4.5 Italy Diabetes Devices and Drugs Market Size, 2016-2027
  6.4.6 Russia Diabetes Devices and Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries Diabetes Devices and Drugs Market Size, 2016-2027
  6.4.8 Benelux Diabetes Devices and Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Diabetes Devices and Drugs Revenue, 2016-2027
  6.5.2 China Diabetes Devices and Drugs Market Size, 2016-2027
  6.5.3 Japan Diabetes Devices and Drugs Market Size, 2016-2027
  6.5.4 South Korea Diabetes Devices and Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia Diabetes Devices and Drugs Market Size, 2016-2027
  6.5.6 India Diabetes Devices and Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Diabetes Devices and Drugs Revenue, 2016-2027
  6.6.2 Brazil Diabetes Devices and Drugs Market Size, 2016-2027
  6.6.3 Argentina Diabetes Devices and Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetes Devices and Drugs Revenue, 2016-2027
  6.7.2 Turkey Diabetes Devices and Drugs Market Size, 2016-2027
  6.7.3 Israel Diabetes Devices and Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia Diabetes Devices and Drugs Market Size, 2016-2027
  6.7.5 UAE Diabetes Devices and Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Medtronic
  7.1.1 Medtronic Corporate Summary
  7.1.2 Medtronic Business Overview
  7.1.3 Medtronic Diabetes Devices and Drugs Major Product Offerings
  7.1.4 Medtronic Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.1.5 Medtronic Key News
7.2 BD
  7.2.1 BD Corporate Summary
  7.2.2 BD Business Overview
  7.2.3 BD Diabetes Devices and Drugs Major Product Offerings
  7.2.4 BD Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.2.5 BD Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Diabetes Devices and Drugs Major Product Offerings
  7.3.4 Johnson & Johnson Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.3.5 Johnson & Johnson Key News
7.4 Abbott Laboratories
  7.4.1 Abbott Laboratories Corporate Summary
  7.4.2 Abbott Laboratories Business Overview
  7.4.3 Abbott Laboratories Diabetes Devices and Drugs Major Product Offerings
  7.4.4 Abbott Laboratories Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.4.5 Abbott Laboratories Key News
7.5 Novo Nordisk
  7.5.1 Novo Nordisk Corporate Summary
  7.5.2 Novo Nordisk Business Overview
  7.5.3 Novo Nordisk Diabetes Devices and Drugs Major Product Offerings
  7.5.4 Novo Nordisk Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.5.5 Novo Nordisk Key News
7.6 Bristol-Myers Squibb
  7.6.1 Bristol-Myers Squibb Corporate Summary
  7.6.2 Bristol-Myers Squibb Business Overview
  7.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Major Product Offerings
  7.6.4 Bristol-Myers Squibb Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.6.5 Bristol-Myers Squibb Key News
7.7 DexCom
  7.7.1 DexCom Corporate Summary
  7.7.2 DexCom Business Overview
  7.7.3 DexCom Diabetes Devices and Drugs Major Product Offerings
  7.4.4 DexCom Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.7.5 DexCom Key News
7.8 Companion Medical
  7.8.1 Companion Medical Corporate Summary
  7.8.2 Companion Medical Business Overview
  7.8.3 Companion Medical Diabetes Devices and Drugs Major Product Offerings
  7.8.4 Companion Medical Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.8.5 Companion Medical Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Diabetes Devices and Drugs Major Product Offerings
  7.9.4 GlaxoSmithKline Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.9.5 GlaxoSmithKline Key News
7.10 Glenmark Pharmaceuticals
  7.10.1 Glenmark Pharmaceuticals Corporate Summary
  7.10.2 Glenmark Pharmaceuticals Business Overview
  7.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Major Product Offerings
  7.10.4 Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.10.5 Glenmark Pharmaceuticals Key News
7.11 Novartis
  7.11.1 Novartis Corporate Summary
  7.11.2 Novartis Business Overview
  7.11.3 Novartis Diabetes Devices and Drugs Major Product Offerings
  7.11.4 Novartis Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.11.5 Novartis Key News
7.12 Roche
  7.12.1 Roche Corporate Summary
  7.12.2 Roche Business Overview
  7.12.3 Roche Diabetes Devices and Drugs Major Product Offerings
  7.12.4 Roche Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.12.5 Roche Key News
7.13 Sanofi
  7.13.1 Sanofi Corporate Summary
  7.13.2 Sanofi Business Overview
  7.13.3 Sanofi Diabetes Devices and Drugs Major Product Offerings
  7.13.4 Sanofi Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.13.5 Sanofi Key News
7.14 MSD
  7.14.1 MSD Corporate Summary
  7.14.2 MSD Business Overview
  7.14.3 MSD Diabetes Devices and Drugs Major Product Offerings
  7.14.4 MSD Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.14.5 MSD Key News
7.15 Astrazeneca
  7.15.1 Astrazeneca Corporate Summary
  7.15.2 Astrazeneca Business Overview
  7.15.3 Astrazeneca Diabetes Devices and Drugs Major Product Offerings
  7.15.4 Astrazeneca Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.15.5 Astrazeneca Key News
7.16 Takeda
  7.16.1 Takeda Corporate Summary
  7.16.2 Takeda Business Overview
  7.16.3 Takeda Diabetes Devices and Drugs Major Product Offerings
  7.16.4 Takeda Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.16.5 Takeda Key News
7.17 North China Pharmaceutical Group Corporation
  7.17.1 North China Pharmaceutical Group Corporation Corporate Summary
  7.17.2 North China Pharmaceutical Group Corporation Business Overview
  7.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Major Product Offerings
  7.17.4 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.17.5 North China Pharmaceutical Group Corporation Key News
7.18 Huadong Medicine
  7.18.1 Huadong Medicine Corporate Summary
  7.18.2 Huadong Medicine Business Overview
  7.18.3 Huadong Medicine Diabetes Devices and Drugs Major Product Offerings
  7.18.4 Huadong Medicine Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.18.5 Huadong Medicine Key News
7.19 Dongbao Pharmaceutical
  7.19.1 Dongbao Pharmaceutical Corporate Summary
  7.19.2 Dongbao Pharmaceutical Business Overview
  7.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Major Product Offerings
  7.19.4 Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.19.5 Dongbao Pharmaceutical Key News
7.20 Hisun Pharmacy
  7.20.1 Hisun Pharmacy Corporate Summary
  7.20.2 Hisun Pharmacy Business Overview
  7.20.3 Hisun Pharmacy Diabetes Devices and Drugs Major Product Offerings
  7.20.4 Hisun Pharmacy Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.20.5 Hisun Pharmacy Key News
7.21 KELUN
  7.21.1 KELUN Corporate Summary
  7.21.2 KELUN Business Overview
  7.21.3 KELUN Diabetes Devices and Drugs Major Product Offerings
  7.21.4 KELUN Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.21.5 KELUN Key News
7.22 Ginwa
  7.22.1 Ginwa Corporate Summary
  7.22.2 Ginwa Business Overview
  7.22.3 Ginwa Diabetes Devices and Drugs Major Product Offerings
  7.22.4 Ginwa Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.22.5 Ginwa Key News
7.23 Tianan Pharmaceutical
  7.23.1 Tianan Pharmaceutical Corporate Summary
  7.23.2 Tianan Pharmaceutical Business Overview
  7.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Major Product Offerings
  7.23.4 Tianan Pharmaceutical Diabetes Devices and Drugs Revenue in Global (2016-2021)
  7.23.5 Tianan Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Diabetes Devices and Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetes Devices and Drugs Market Drivers in Global Market
Table 3. Diabetes Devices and Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetes Devices and Drugs in Global Market
Table 5. Top Diabetes Devices and Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Diabetes Devices and Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Diabetes Devices and Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Diabetes Devices and Drugs Product Type
Table 9. List of Global Tier 1 Diabetes Devices and Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Devices and Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Diabetes Devices and Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Diabetes Devices and Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Diabetes Devices and Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Diabetes Devices and Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Diabetes Devices and Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Diabetes Devices and Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Diabetes Devices and Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Diabetes Devices and Drugs Product Offerings
Table 32. Medtronic Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 33. BD Corporate Summary
Table 34. BD Diabetes Devices and Drugs Product Offerings
Table 35. BD Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Diabetes Devices and Drugs Product Offerings
Table 38. Johnson & Johnson Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Abbott Laboratories Corporate Summary
Table 40. Abbott Laboratories Diabetes Devices and Drugs Product Offerings
Table 41. Abbott Laboratories Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Novo Nordisk Corporate Summary
Table 43. Novo Nordisk Diabetes Devices and Drugs Product Offerings
Table 44. Novo Nordisk Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Diabetes Devices and Drugs Product Offerings
Table 47. Bristol-Myers Squibb Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 48. DexCom Corporate Summary
Table 49. DexCom Diabetes Devices and Drugs Product Offerings
Table 50. DexCom Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Companion Medical Corporate Summary
Table 52. Companion Medical Diabetes Devices and Drugs Product Offerings
Table 53. Companion Medical Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Diabetes Devices and Drugs Product Offerings
Table 56. GlaxoSmithKline Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Glenmark Pharmaceuticals Corporate Summary
Table 58. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product Offerings
Table 59. Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 60. Novartis Corporate Summary
Table 61. Novartis Diabetes Devices and Drugs Product Offerings
Table 62. Novartis Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 63. Roche Corporate Summary
Table 64. Roche Diabetes Devices and Drugs Product Offerings
Table 65. Roche Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 66. Sanofi Corporate Summary
Table 67. Sanofi Diabetes Devices and Drugs Product Offerings
Table 68. Sanofi Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 69. MSD Corporate Summary
Table 70. MSD Diabetes Devices and Drugs Product Offerings
Table 71. MSD Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 72. Astrazeneca Corporate Summary
Table 73. Astrazeneca Diabetes Devices and Drugs Product Offerings
Table 74. Astrazeneca Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 75. Takeda Corporate Summary
Table 76. Takeda Diabetes Devices and Drugs Product Offerings
Table 77. Takeda Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 78. North China Pharmaceutical Group Corporation Corporate Summary
Table 79. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product Offerings
Table 80. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 81. Huadong Medicine Corporate Summary
Table 82. Huadong Medicine Diabetes Devices and Drugs Product Offerings
Table 83. Huadong Medicine Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 84. Dongbao Pharmaceutical Corporate Summary
Table 85. Dongbao Pharmaceutical Diabetes Devices and Drugs Product Offerings
Table 86. Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 87. Hisun Pharmacy Corporate Summary
Table 88. Hisun Pharmacy Diabetes Devices and Drugs Product Offerings
Table 89. Hisun Pharmacy Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 90. KELUN Corporate Summary
Table 91. KELUN Diabetes Devices and Drugs Product Offerings
Table 92. KELUN Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 93. Ginwa Corporate Summary
Table 94. Ginwa Diabetes Devices and Drugs Product Offerings
Table 95. Ginwa Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)
Table 96. Tianan Pharmaceutical Corporate Summary
Table 97. Tianan Pharmaceutical Diabetes Devices and Drugs Product Offerings
Table 98. Tianan Pharmaceutical Diabetes Devices and Drugs Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Diabetes Devices and Drugs Segment by Type
Figure 2. Diabetes Devices and Drugs Segment by Application
Figure 3. Global Diabetes Devices and Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Diabetes Devices and Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Diabetes Devices and Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2020
Figure 8. By Type - Global Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 12. US Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 24. China Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Diabetes Devices and Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Diabetes Devices and Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Medtronic Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BD Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Johnson & Johnson Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Abbott Laboratories Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novo Nordisk Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bristol-Myers Squibb Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. DexCom Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Companion Medical Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. GlaxoSmithKline Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Novartis Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Roche Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Sanofi Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. MSD Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Astrazeneca Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Takeda Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Huadong Medicine Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Hisun Pharmacy Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. KELUN Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Ginwa Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications